Amneal Pharmaceuticals is up 17.2%, or 58c to $3.94.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AMRX:
- Amneal Pharmaceuticals raises FY23 EPS view to 51c-58c from 45c-55c
- Amneal Pharmaceuticals reports preliminary Q3 revenue $610M-$620M
- Amneal adds 2 denosumab biosimilars to U.S. pipeline oncology portfolio
- Amneal Pharmaceuticals management to meet with Trust
- Amneal Pharmaceuticals gets FDA approval for calcium gluconate injection